1. Home
  2. LNC vs CYTK Comparison

LNC vs CYTK Comparison

Compare LNC & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lincoln National Corporation

LNC

Lincoln National Corporation

HOLD

Current Price

$43.83

Market Cap

8.5B

Sector

Finance

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$62.41

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LNC
CYTK
Founded
1905
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Life Insurance
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
8.0B
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
LNC
CYTK
Price
$43.83
$62.41
Analyst Decision
Hold
Strong Buy
Analyst Count
12
16
Target Price
$45.67
$82.38
AVG Volume (30 Days)
1.5M
2.2M
Earning Date
02-12-2026
02-26-2026
Dividend Yield
4.11%
N/A
EPS Growth
626.01
N/A
EPS
11.17
N/A
Revenue
$18,426,000,000.00
$87,211,000.00
Revenue This Year
$6.97
$346.43
Revenue Next Year
$4.77
$57.69
P/E Ratio
$3.92
N/A
Revenue Growth
35.24
2609.26
52 Week Low
$27.58
$29.31
52 Week High
$46.82
$70.98

Technical Indicators

Market Signals
Indicator
LNC
CYTK
Relative Strength Index (RSI) 46.05 49.43
Support Level $44.01 $62.05
Resistance Level $46.82 $66.59
Average True Range (ATR) 1.01 2.97
MACD -0.34 0.09
Stochastic Oscillator 12.06 33.47

Price Performance

Historical Comparison
LNC
CYTK

About LNC Lincoln National Corporation

Lincoln National Corp operates multiple insurance and retirement businesses. The company's operating segment includes Annuities; Retirement Plan Services; Life Insurance and Group Protection. Its products include fixed and indexed annuities, variable annuities, universal life insurance (UL), variable universal life insurance (VUL), linked-benefit UL and VUL, indexed universal life insurance (IUL), term life insurance, employer-sponsored retirement plans and services, and group life, disability and dental.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: